Mark Larché
Director/Board Member at British Society for Immunology
Profile
Mark Larché is the founder of Circassia Ltd.
(1998) and Niox Group Plc (2006).
He is currently the Director of the British Society for Immunology and a Professor at McMaster University.
He formerly worked as the Chairman-Asthma Section at Allergy & Clinical Immunology Associates, Inc. from 2001 to 2005.
Mark Larché active positions
| Companies | Position | Start |
|---|---|---|
| McMaster University | Corporate Officer/Principal | 22/04/2010 |
British Society for Immunology
 British Society for Immunology Miscellaneous Commercial ServicesCommercial Services The British Society for Immunology provides membership organization services. The non-profit company is based in London, UK. | Director/Board Member | 22/04/2010 |
Former positions of Mark Larché
| Companies | Position | End |
|---|---|---|
| Allergy & Clinical Immunology Associates, Inc. | Corporate Officer/Principal | 31/12/2004 |
| NIOX GROUP PLC | Founder | - |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NIOX GROUP PLC | Health Services |
| Private companies | 3 |
|---|---|
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services The British Society for Immunology provides membership organization services. The non-profit company is based in London, UK. | Commercial Services |
| Allergy & Clinical Immunology Associates, Inc. | |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Mark Larché
